サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1370360

大腸菌検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
大腸菌検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要 2023-2028年

世界の大腸菌検査市場規模は2022年に20億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに31億米ドルに達し、2023年から2028年の間に7.65%の成長率（CAGR）を示すと予測しています。

大腸菌（E. Coli）検査とは、食品由来病原体の存在を検出・監視するプロセスを指します。大腸菌は通常、汚染された食品や水、生乳から製造されたチーズ、加熱不十分な製品、未殺菌乳、生の果物や野菜から検出されます。食中毒、肺炎、尿路感染症（UTI）など様々な病気を引き起こす可能性があります。大腸菌を検出する臨床検査法には、酵素免疫測定法（EIA）やポリメラーゼ連鎖反応法（PCR）、酵素基質法、膜ろ過法、多管発酵法（MTF）などの環境検査法があります。これらの技術は、サンプル中に存在する総大腸菌群や細菌を正確かつ定量的に測定するのに役立ちます。

下痢や溶血性尿毒症症候群（HUS）のような水を媒介とする疾病の有病率の増加と、清潔な飲料水に対する世界のニーズの高まりは、市場の前向きな見通しを生み出す重要な要因の一つです。大腸菌検査は、病気や疾患の蔓延を防ぐため、地表水や飲料水の水質モニタリングに役立ちます。さらに、菌の有無（P/A）検査として酵素基質検査が広く採用されていることも、市場の成長を後押ししています。これらの検査は実施が容易で、高度な実験装置を必要とせず、加水分解可能な蛍光基質を使用して細菌が産生する様々な酵素の存在を検出します。さらに、革新的な細菌診断機器や水質検査法の市場開拓など、さまざまな技術の進歩も市場成長に寄与しています。その他の要因としては、大衆の健康意識の高まり、微生物学分野における広範な研究開発（R&D）活動などが挙げられ、市場のさらなる牽引役となることが期待されます。

本レポートで扱う主な質問

  • 世界の大腸菌検査市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の大腸菌検査市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 検査タイプ別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の大腸菌検査市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 大腸菌検査の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 消耗品
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第7章 市場内訳：検査タイプ別

  • 環境試験
    • 市場動向
    • 主要タイプ
      • 膜ろ過（MF）
      • 多重管発酵法（MTF）
      • 酵素基質法
    • 市場予測
  • 臨床試験
    • 市場動向
    • 主な種類
      • ポリメラーゼ連鎖反応（PCR）検査法
      • 酵素免疫測定法（EIA）
      • その他
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accugen Laboratories Inc.
    • Alere Inc.（Abbott Laboratories）
    • BD（Becton Dickinson and Company）
    • bioMerieux（INSTITUT MERIEUX）
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.（Enzo Biochem Inc.）
    • Idexx Laboratories Inc.
    • Johnson & Johnson
    • Meridian Bioscience Inc.
    • Nanologix Inc.
    • Pro-Lab Diagnostics
    • Qiagen N.V.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: E. Coli Testing Market: Major Drivers and Challenges
  • Figure 2: Global: E. Coli Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: E. Coli Testing Market: Breakup by Product (in %), 2022
  • Figure 4: Global: E. Coli Testing Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: E. Coli Testing Market: Breakup by End User (in %), 2022
  • Figure 6: Global: E. Coli Testing Market: Breakup by Region (in %), 2022
  • Figure 7: Global: E. Coli Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: E. Coli Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: E. Coli Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: E. Coli Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: E. Coli Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: E. Coli Testing (Environmental Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: E. Coli Testing (Environmental Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: E. Coli Testing (Clinical Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: E. Coli Testing (Clinical Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: E. Coli Testing (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: E. Coli Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: E. Coli Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: E. Coli Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: E. Coli Testing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: E. Coli Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: North America: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: North America: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: United States: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: United States: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Canada: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Canada: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Asia Pacific: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Asia Pacific: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: China: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: China: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Japan: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Japan: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: India: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: India: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: South Korea: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: South Korea: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Australia: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Australia: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Indonesia: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Indonesia: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Others: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Others: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Europe: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Europe: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Germany: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Germany: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: France: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: France: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: United Kingdom: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: United Kingdom: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Italy: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Italy: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Spain: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Spain: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Russia: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Russia: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Latin America: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Latin America: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Brazil: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Brazil: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Mexico: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Mexico: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Middle East and Africa: E. Coli Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Middle East and Africa: E. Coli Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: E. Coli Testing Industry: SWOT Analysis
  • Figure 71: Global: E. Coli Testing Industry: Value Chain Analysis
  • Figure 72: Global: E. Coli Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: E. Coli Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: E. Coli Testing Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: E. Coli Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: E. Coli Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: E. Coli Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: E. Coli Testing Market Structure
  • Table 7: Global: E. Coli Testing Market: Key Players
目次
Product Code: SR112023A2368

Abstract

Market Overview 2023-2028:

The global E. coli testing market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs). Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.

The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria. Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global E. coli testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type and end user.

Breakup by Product:

Consumables

Instruments

Breakup by Test Type:

Environmental Test

Membrane Filtration (MF)

Multiple Tube Fermentation (MTF)

Enzyme Substrate Methods

Clinical Test

Polymerase Chain Reaction (PCR) Tests

Enzyme Immunoassays (EIA)

Others

Breakup by End User:

Hospitals and Clinics

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMerieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global E. coli testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global E. coli testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global E. coli testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global E. Coli Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Environmental Test
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Membrane Filtration (MF)
      • 7.1.2.2 Multiple Tube Fermentation (MTF)
      • 7.1.2.3 Enzyme Substrate Methods
    • 7.1.3 Market Forecast
  • 7.2 Clinical Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Polymerase Chain Reaction (PCR) Tests
      • 7.2.2.2 Enzyme Immunoassays (EIA)
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accugen Laboratories Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alere Inc. (Abbott Laboratories)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 bioMerieux (INSTITUT MERIEUX)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc. (Enzo Biochem Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Idexx Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Meridian Bioscience Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Nanologix Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Pro-Lab Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Qiagen N.V.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis